This article is more than 5 years old. Information may no longer be current.

FDA approves Allergan SoftTouch breast implants

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA has approved a breast implant offered by Allergen plc for women undergoing reconstructive or revision surgery.

The Natrelle Inspira SoftTouch, which can also be used for breast augmentation, is a new option offering a medium firmness cohesive implant, according to an Allergan release.

Natrelle is the only breast implant line with three levels of cohesive gel, the release added.

The FDA approved Natrelle for breast augmentation with silicone-filled implants in women aged 22 years or older. It has also granted approval to the implant line for augmentation with saline-filled implants in woman age 18 and older.

Complications associated with breast implants include repeat operations, implant removal or replacement, rupturing of silicone-filled implants, deflation of saline-filled implants and severe scarring.